Literature DB >> 15395954

Prothrombin consumption, serum prothrombic activity and prothrombin conversion accelerator in hemophilia and thrombocytopenia.

B ALEXANDER, G LANDWEHR.   

Abstract

Entities:  

Keywords:  BLOOD; HEMOPHILIA; PROTHROMBIN

Mesh:

Substances:

Year:  1949        PMID: 15395954      PMCID: PMC439708          DOI: 10.1172/JCI102217

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  3 in total

1.  The Function of Ac-Globulin in Blood Clotting.

Authors:  A G Ware; R C Murphy; W H Seegers
Journal:  Science       Date:  1947-12-19       Impact factor: 47.728

2.  A Prothrombin Conversion Accelerator in Serum.

Authors:  B Alexander; A de Vries; R Goldstein; G Landwehr
Journal:  Science       Date:  1949-05-27       Impact factor: 47.728

3.  THE COAGULATION DEFECT IN HEMOPHILIA. THE EFFECT IN HEMOPHILIA OF INTRAMUSCULAR ADMINISTRATION. OF A GLOBULIN SUBSTANCE DERIVED FROM NORMAL HUMAN PLASMA.

Authors:  F J Pohle; F H Taylor
Journal:  J Clin Invest       Date:  1937-09       Impact factor: 14.808

  3 in total
  4 in total

1.  The labile factor of prothrombin conversion: its consumption under normal and pathological conditions affecting blood coagulation.

Authors:  B ALEXANDER; R GOLDSTEIN; G LANDWEHR
Journal:  J Clin Invest       Date:  1951-03       Impact factor: 14.808

2.  Congenital SPCA deficiency: a hitherto unrecognized coagulation defect with hemorrhage rectified by serum and serum fractions.

Authors:  B ALEXANDER; R GOLDSTEIN; G LANDWEHR; C D COOK
Journal:  J Clin Invest       Date:  1951-06       Impact factor: 14.808

3.  The prothrombin conversion accelerator of serum (SPCA): its partial purification and its properties compared with serum AC-globulin.

Authors:  B ALEXANDER; R GOLDSTEIN; G LANDWEHR
Journal:  J Clin Invest       Date:  1950-07       Impact factor: 14.808

4.  Influence of the physiological blood clotting process on the coagulation of blood by staphylocoagulase.

Authors:  M TAGER; A L LODGE
Journal:  J Exp Med       Date:  1951-07-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.